NFKB1 and neoplasm: Additionally, Prist exhibits anticancer and antiproliferative properties that are attributed to its ability to block NF-κB activation in tumor cell proliferation [18], and to inhibit proteasome activity, tumor cell motility, and angiogenesis [22].